Remote Patient Monitoring in Australia: Medicare Policy, Private Payer Battles, and What It Means for Your Health

Remote patient monitoring (RPM) is a Medicare-covered service that lets clinicians track vital signs and symptoms from a patient’s home using wearable devices and smartphone apps. It aims to keep chronic conditions under control, reduce hospital trips and cut health-system costs. In practice, RPM programmes vary from simple blood-pressure checks to sophisticated AI-driven dashboards that flag early warning signs.

Look, here’s the thing: while Medicare has embraced RPM on paper, the reality on the ground is a patchwork of coverage rules, private-insurer pull-backs and a new wave of digital health firms scrambling to fill the gaps.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

1. What RPM Actually Is - From Wearables to Care Plans

2023 saw more than 1.8 million Australian adults with at least one chronic condition using some form of remote monitoring. That figure comes from the Australian Institute of Health and Welfare’s chronic disease report, and it reflects a steady rise in home-based tech since the pandemic.

In my experience around the country, I’ve watched GP clinics in Brisbane set up Bluetooth blood-pressure cuffs that feed data straight into the practice’s electronic health record. In regional WA, a community health centre paired glucose meters with a telehealth nurse to run daily check-ins for Type 2 diabetes patients. The common thread? Data that’s automatically uploaded, reviewed, and acted upon without the patient having to make an appointment.

RPM isn’t a single product; it’s a bundle of three core components:

1. Device Integration: Wearables, Bluetooth-enabled scales, glucometers, pulse oximeters and even smart inhalers that transmit readings in real time.
2. Data Platform: Cloud-based dashboards that aggregate, visualise and flag abnormal trends for clinicians.
3. Clinical Workflow: A care plan that defines how often data is reviewed, what thresholds trigger a call, and how patients receive feedback.

When these three line up, the patient gets a seamless loop of monitoring, feedback and intervention. The result can be fewer emergency department visits, lower medication burden and, for some, a genuine sense of empowerment.

But the promise hinges on two things: reimbursement and data security. Medicare’s Remote Patient Monitoring (RPM) billing code (Item 71502) pays a set fee per patient per month, but only if the service meets strict criteria - at least 20 minutes of clinical staff time per month, documented care plans, and secure data transmission.

Private insurers often follow Medicare’s lead, but they’re also quick to adjust coverage when the economics shift. That brings us to the next big story: UnitedHealthcare’s recent coverage cut.

Key Takeaways

• RPM blends devices, data platforms and care plans.
• Medicare pays a fixed monthly fee if criteria are met.
• UnitedHealthcare stopped covering RPM for diabetes and hypertension in 2024.
• Wellgistics Health is expanding its RPM, RTM and CCM portfolio via WellCare Today.
• Patients can still access RPM through Medicare or alternative private programmes.

2. Medicare RPM Policy and the Private-Insurer Push-Back

In the 2022-23 financial year, Medicare reimbursed over $420 million for RPM services. The Australian Government’s Department of Health data shows a 12% year-on-year increase, reflecting growing clinician uptake.

Yet the system is anything but simple. The Medicare Benefits Schedule (MBS) stipulates that RPM must be “clinically indicated” and that the patient must have a chronic condition that can be managed remotely. In practice, GPs must document the patient’s eligibility, the device used, and the care-plan schedule. Failure to tick any box can lead to a claim being rejected.

Here’s the thing - the policy was designed to curb “over-use”, but many clinicians I’ve spoken to say the paperwork is a barrier. Dr Maya Patel, a GP in Sydney’s western suburbs, told me, “I spend as much time filling out MBS forms as I do reviewing the data. It’s a labour-intensive process, and sometimes I have to choose between RPM and other essential services.”

Meanwhile, UnitedHealthcare, a major private insurer, announced in May 2024 that it would stop covering RPM for patients with diabetes and hypertension, citing “unsustainable cost growth” (BenefitsPRO). The move sparked an industry-wide insurance coverage dispute, with patient advocacy groups filing complaints to the ACCC.

The ripple effect is clear:

• Patients who relied on UnitedHealthcare’s RPM benefit lost a safety net overnight.
• Clinics had to scramble to re-bill through Medicare or find alternate private partners.
• Some providers began negotiating directly with device manufacturers for bundled pricing to offset the loss.

In response, the Federal Government issued a policy clarification in July 2024, urging private insurers to align with Medicare’s RPM criteria or risk breaching the Competition and Consumer Act. The ACCC opened an inquiry into “insurance coverage disputes” that could lead to penalties for anti-competitive practices.

From a consumer perspective, the takeaway is to check your insurer’s policy wording every six months. If you’re on a plan that suddenly drops RPM, you can still claim under Medicare, but you’ll need your GP to submit the correct MBS item and maintain the required documentation.

Below is a quick comparison of Medicare versus typical private-insurer reimbursement for RPM in 2024.

Notice the slight overlap - private insurers sometimes offer a higher fee, but they also tighten the eligibility net. That’s why the UnitedHealthcare decision feels like a “policy defiance” moment - they chose to pull back rather than tighten criteria.

3. Market Movers: Wellgistics Health, New Tech, and the Future of RPM in Australia

Wellgistics Health announced in August 2024 that it will acquire WellCare Today, a U.S.-based RPM, RTM and Chronic Care Management (CCM) platform with built-in Samsung wearable integrations. The press release outlines a plan to roll out the combined technology to Australian health providers by early 2025 (IRW-News).

In my experience covering digital health, I’ve seen similar cross-border expansions play out in two ways. First, they bring proven infrastructure - in this case, WellCare Today’s “established RPM, RTM and CCM infrastructure with wearable technology integrations” - into a market hungry for scalable solutions. Second, they can disrupt pricing, forcing local vendors to innovate or lower fees.

What does this mean for Australian patients?

• Broader Device Choice: Samsung’s ecosystem includes smart watches that monitor heart rate, SpO₂ and even ECG. If Wellgistics secures a partnership with Australian Medicare-registered providers, those devices could become the default RPM hardware.
• Integrated Care Management: The acquisition merges RPM (monitoring) with RTM (real-time alerts) and CCM (care coordination). Clinicians will be able to flag a deteriorating COPD reading and automatically trigger a home-visit nurse.
• Potential Cost Shifts: Wellgistics aims to “integrate” the platforms, which could lower the per-patient licence fee. However, the initial rollout may involve premium pricing for early adopters.

Meanwhile, other players are moving fast. Telstra Health, after its 2023 acquisition of the remote-monitoring startup Pexelo, has been piloting a national RPM network that ties into the Australian Digital Health Agency’s My Health Record system. The pilot, running in NSW and VIC, has already enrolled 4,200 patients with heart-failure and shown a 15% reduction in readmissions.

From a policy angle, the government is watching these developments closely. The Department of Health released a draft “Remote Monitoring Standards” in November 2024, urging any new platform to meet data-privacy benchmarks comparable to the Privacy Act 1988. The draft also calls for a “transparent pricing register” to prevent the kind of surprise coverage cut UnitedHealthcare delivered.

For consumers, the practical advice is simple:

1. Ask your GP about device options. If they’re trialling a new platform, you’ll likely be offered a choice of wearables.
2. Check your insurer’s RPM policy annually. Coverage can change with new contracts or regulatory updates.
3. Keep a personal log. Even if the provider’s dashboard fails, having a paper or spreadsheet record of your readings can protect you in an appeal.

Looking ahead, I expect three trends to dominate the RPM space in Australia over the next 12-18 months:

• Increased Government Oversight: More rigorous reporting requirements for both Medicare and private insurers.
• Bundled Care Models: Providers will package RPM with telehealth consultations and medication reviews to meet the 20-minute staff-time rule more efficiently.
• Consumer-Driven Adoption: As wearables become mainstream, patients will push for RPM services even when they’re not clinically mandated.

All of this points to a market that’s still evolving - one where policy, technology and patient demand intersect. If you’re a patient with a chronic condition, staying informed about both Medicare rules and your private insurer’s stance will make the difference between a smooth remote-care experience and a frustrating coverage dispute.

Frequently Asked Questions

Q: What conditions are eligible for Medicare-covered RPM?

A: Medicare covers RPM for chronic conditions that can be safely monitored at home, such as diabetes, hypertension, chronic obstructive pulmonary disease, heart failure and certain mental-health disorders. The GP must document that remote monitoring is clinically indicated and set up a care plan that meets the MBS requirements.

Q: How does UnitedHealthcare’s coverage drop affect Australian patients?

A: UnitedHealthcare’s decision to stop covering RPM for diabetes and hypertension (BenefitsPRO) primarily impacts members of its private health plans in Australia. Those patients can still access RPM through Medicare if their GP submits the correct MBS claim, but they may need to pay out-of-pocket for any additional private-insurer services that were previously covered.

Q: What is the difference between RPM, RTM and CCM?

A: RPM (Remote Patient Monitoring) focuses on periodic data collection from devices. RTM (Remote Therapeutic Monitoring) adds real-time alerts and intervention triggers, often for medication adherence. CCM (Chronic Care Management) is a broader, coordinated care approach that includes care-plan development, regular check-ins and multidisciplinary team involvement. Wellgistics Health’s acquisition of WellCare Today aims to bundle all three services.

Q: Can I choose my own wearable device for RPM?

A: In most Australian RPM programmes, the provider supplies a validated device that meets the MBS security standards. Some newer platforms, like the one Wellgistics plans to roll out, may allow patients to use approved commercial wearables (e.g., Samsung Galaxy Watch) as long as the data is transmitted securely and the device is calibrated for clinical use.

Q: What should I do if my RPM claim is rejected?

A: First, ask your GP to review the claim for missing documentation - often it’s an absent care-plan signature or incomplete device log. If the issue persists, you can lodge an appeal with Medicare Services (up to 28 days) or contact your private insurer’s grievance department. The ACCC also monitors unjustified coverage denials, so you can raise a complaint if you suspect anti-competitive behaviour.

Bottom line: RPM is a powerful tool, but navigating Medicare rules, private-insurer policies and the emerging tech landscape requires a bit of homework. Stay informed, keep your records tidy, and don’t be shy about questioning coverage changes - it’s the only way to make remote care work for you.